LUND, Sweden & LONDON--(BUSINESS WIRE)--BioInvent International AB (OMXS: BINV) and Cancer Research Technology Ltd (CRT), the commercial arm of Cancer Research UK, announced today that they have entered a collaboration with Queen Mary, University of London, to identify new therapeutic antibodies in oncology.
